III Capital Management’s eFFECTOR Therapeutics, Inc. Warrant EFTRW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-36,579
| Closed | -$45 | – | 108 |
|
|
2024
Q2 | $45 | Sell |
36,579
-5,216
| -12% | -$6 | ﹤0.01% | 96 |
|
|
2024
Q1 | $5.75K | Hold |
41,795
| – | – | ﹤0.01% | 92 |
|
|
2023
Q4 | $4.43K | Hold |
41,795
| – | – | ﹤0.01% | 104 |
|
|
2023
Q3 | $4.51K | Hold |
41,795
| – | – | ﹤0.01% | 120 |
|
|
2023
Q2 | $7.25K | Hold |
41,795
| – | – | ﹤0.01% | 104 |
|
|
2023
Q1 | $4.15K | Hold |
41,795
| – | – | ﹤0.01% | 106 |
|
|
2022
Q4 | $4K | Hold |
41,795
| – | – | ﹤0.01% | 110 |
|
|
2022
Q3 | $7K | Hold |
41,795
| – | – | ﹤0.01% | 128 |
|
|
2022
Q2 | $9K | Hold |
41,795
| – | – | ﹤0.01% | 157 |
|
|
2022
Q1 | $16K | Buy |
41,795
+15,895
| +61% | +$6.09K | ﹤0.01% | 134 |
|
|
2021
Q4 | $23K | Buy |
25,900
+9,396
| +57% | +$8.34K | ﹤0.01% | 137 |
|
|
2021
Q3 | $26K | Buy |
+16,504
| New | +$26K | ﹤0.01% | 149 |
|